Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy

Not Applicable

Terminated

Conditions: Hypersomnia

Interventions: Device: Sham stimulation
Device: Transcranial Direct Current Stimulation

Registration Number: NCT03198156

Lead Sponsor: Ohio State University

Brief Summary: 1. To determine the effects of transcranial direct current stimulation (tDCS) on vigilance in subjects with central hypersomnia without cataplexy.

2. To determine the effects of tDCS on subjective measures of sleepiness and alertness in subjects with central hypersomnia without cataplexy.

Detailed Description: This is a randomized, sham-controlled, parallel group study. The study will last up to 5 weeks. After informed consent, subjects with idiopathic hypersomnia with an MSLT mean sleep latency of \>8 minutes will undergo actigraphy and those with an average sleep time of \>10 hours per day will continue with the study while those with \<10 hours sleep time will be excluded. In addition, OSA subjects with complaints of hypersomnia with an ESS score \<10 will also be excluded. Female subjects of child bearing age and not menopausal will have a pregnancy test performed as pregnancy is an exclusionary criteria.

Subjects will be randomized to receive either active tDCS or sham stimulation for 30 minutes daily for 4 sessions. The randomization will be generated by means of a computer-generated random-number table. An unrestricted randomization scheme will be followed. Subjects will be blinded as to whether they are receiving sham or active tDCS treatments. The investigator who will conduct the analysis of all outcomes will be blinded as to subject treatment assignment.

All stimulation visits will be completed within a five-consecutive day period; that is one stimulation visit may be missed provided a total of four stimulation visits are completed within a five-day period. Outcome measures will include: psychomotor vigilance test (PVT), subjective measures of sleepiness, and the Center for Epidemiologic Studies Depression (CES-D) scale. PVT will be performed pre- and post- stimulation during the first and last stimulation sessions. Subjective measures of sleepiness include the following: Epworth Sleepiness Scale (ESS), Stanford Sleepiness Scale (SSS), Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10), and Visual Analogue Scale (VAS).

Recruitment & Eligibility

Status: TERMINATED

Sex: All

Target Recruitment: 39

Inclusion Criteria

Age 18 - 70 years
Epworth Sleepiness scale score >10
Stable medication dosage over previous 4 weeks
Able to understand English and read and write at the 8th grade level and give a written informed consent document.
Stable sleep/wake schedule (that is, no rotating shift work)
Clinical diagnosis of any of the following:
1. Idiopathic Hypersomnia
2. Narcolepsy without Cataplexy
3. Hypersomnia in OSA patients adequately treated with PAP therapy or dental device
4. Posttraumatic hypersomnia
5. Hypersomnia, unspecified
Multiple sleep latency test (MSLT) shows fewer than two sleep onset REM periods and a mean sleep latency of ≤ 8 minutes. An MSLT is not required for inclusion of OSA patients provided their Epworth Sleepiness Scale (ESS) score is >10. Adequately treated OSA patients will be defined as: i) an average PAP usage of > 4 hours per night and a residual apnea-hypopnea index (AHI) of <10/hour based on PAP machine download during at least a 30-day period, or ii) regular use of dental device during sleep based on self-report and a prior sleep study showing an AHI <10/hour while using the dental device.
Subjects with idiopathic hypersomnia with an MSLT mean sleep latency of > 8 minutes will be included provided they have hypersomnia symptoms and habitually long sleep times (average of >10 hours per day) documented by actigraphy for at least 7 days.18

Exclusion Criteria

Self-reported habitual sleep period of < 7 hours/night
History of automobile accident due to falling asleep while driving
Currently taking stimulant medications such as Modafinil, Armodafinil, Methylphenidate, or Dextroamphetamnie.
Inability to understand or read English
Clear history of cataplexy
Moderate or severe sleep apnea defined as an apnea-hypopnea index (AHI) of > 15/hour based on a previous sleep study and non-compliant with treatment.
Self-reported Substance abuse (current)
Excessive alcohol consumption defined as:
More than 3 glasses of wine a day
More than 3 beers a day
More than 60 mL of hard liquor a day
Presence of cardiac pacemaker or automatic implantable cardioverter-defibrillator (AICD).
Pregnancy, lactation
Recent hospitalization for major surgery/major illness (within past 1 month)
Non-removable metal or tattoos around head
Use of implantable birth control device such as Implanon
History of severe and frequent headaches
Known coronary artery disease
Seizure disorder
Uncontrolled hypertension
Congestive heart failure

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Sham stimulation	Sham stimulation	Sham stimulation sessions will be for 30 minutes daily for each of the 4 sessions; however, active stimulation for this arm of the study is only for 30 seconds; yet, will be applied at the same intensity as the Active arm of the study, albeit for only 30 seconds.
Transcranial Direct Current Stimulation	Transcranial Direct Current Stimulation	Active tDCS for 30 minutes daily for 4 sessions

Primary Outcome Measures

Name	Time	Method
Epworth Sleepiness Scale	5 minutes	Subjective measure of sleepiness
Psychomotor Vigilance Test	10 minutes	Objective measure of sleepiness.

Secondary Outcome Measures

Name	Time	Method
Functional Outcomes of Sleep Questionnaire	5 minutes	Measure of the impact of sleepiness on daytime function
Visual Analogue Scale	5 minutes	Subjective Measure of Sleepiness
Stanford Sleepiness Scale	5 minutes	Subjective measure of sleepiness
CES-D Scale	5 minutes	Center for Epidemiologic Studies Depression (CES-D) Scale